Dr. Axel Thors, DO

Dr. Thors practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Thors' NPI, 1629368089, was assigned on April 19, 2011. Dr. Thors holds Kansas license 05-39724.

Dr. Thors' primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Thors' primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Thors is also affiliated with Providence Medical Center. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Thors to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thors practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Thors' primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Thors is licensed in Kansas.

CMS data shows 480 Medicare services from Dr. Thors across 10 procedure codes in 2024, for 384 Medicare patients. Medicare paid $52,176 for them.

CMS counts 384 Medicare patients who saw Dr. Thors in 2024. The largest group is 75 to 84, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thors' median patient age at 74, with 40% women.

In 2024, Dr. Thors wrote 274 Medicare Part D claims for 90 patients. 77% of them were for generic drugs. CMS names the drug for 212 of them, across 4 drugs with 11 or more claims each, at $48,820 in total drug cost. In 2023, CMS named 233 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Thors for performance year 2024, reported through an alternative payment model (APM). Dr. Thors accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thors as offering telehealth. CMS counts 13 procedures of leg revascularization (restoring blood flow) by Dr. Thors, more than 68% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Thors, published from 2014 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Hospital Mortality, Kidney Failure, Chronic and Peripheral Arterial Disease. Dr. Thors has published most often in Catheter Cardiovasc Interv. Dr. Thors' most frequent co-authors are Kamal Gupta, MD, Kirk A. Hance, FACS, MD and Mounir J. Haurani, MD.

Dmand AI links Dr. Thors to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 474 general payments to Dr. Thors from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 37% of the total. Janssen Pharmaceuticals, Inc paid the most, $39,746.